Press Release
CGT Catapult annual review highlights the role of advanced therapies in supporting Government ambitions for public health and economic growthNew evaluation model finds widespread adoption of cell and gene therapies may unlock billions for the UK economyUnderstanding life with Beta ThalassemiaCGT Catapult supporting VascVersa to develop pre-treatment test to ensure efficacy of cell therapy that regenerates blood vesselsMHRA introduces regulations that allow decentralised manufacturing of therapiesCell and Gene Therapy Catapult appoints Dr Jim Faulkner as new ChairCell and Gene Therapy Catapult appoints Dr Ed Samuel as Chief Operating OfficerSpliceor receives investment from the Cell and Gene Therapy Catapult as part of the Cross-Catapult Investment PilotCGT Catapult response to publication of the Life Sciences Sector PlanCellular Origins, Cell and Gene Therapy Catapult and Resolution Therapeutics form consortium to deliver fully automated robotics CGT manufacturing platformScience Minister Lord Vallance opens Digital and Automation Testbeds that will improve advanced therapies manufacturingCGT Catapult and Nakanoshima Qross to foster stronger relationships between the advanced therapies industry in the UK and Japan